Table 4.
Change in Health-Related Quality of Life at 1-Year Follow-Up and Absolute Values of Health-Related Quality of Life at 1-Year Follow-Upa
| Unweighted |
Weighted |
|||||
|---|---|---|---|---|---|---|
| Myomectomy | Hysterectomy | UAE | Myomectomy | Hysterectomy | UAE | |
| Change in HR-QOL score from baseline to 1-year follow-up | ||||||
| <−10 points of change | 3.4 | 1.6 | 1.3 | 3.2 | 2.4 | 0.8 |
| –10 to 0 points of change | 3.4 | 2.0 | 4.5 | 2.3 | 2.6 | 5.7 |
| 0–10 points of change | 9.6 | 5.3 | 12.3 | 7.5 | 5.7 | 15.9 |
| 10–20 points of change | 15.5 | 7.4 | 6.5 | 10.3 | 7.8 | 4.9 |
| ≥20 points of change | 68.2 | 83.7 | 75.5 | 76.8 | 81.5 | 72.7 |
| p-value trend | <0.0001 | 0.0969 | ||||
| Total HR-QoL score at 1-year follow-up | ||||||
| <80 | 23.1 | 10.5 | 32.3 | 27.0 | 12.7 | 31.8 |
| 80–89 | 12.6 | 6.3 | 15.5 | 12.2 | 6.6 | 15.7 |
| 90–99 | 36.5 | 25.8 | 28.4 | 35.1 | 25.5 | 26.5 |
| 100 | 27.8 | 57.4 | 23.9 | 25.6 | 55.2 | 26.1 |
| p-value trend | <0.0001 | <0.0001 | ||||
| Total HR-QoL score at 1-year follow-up, mean (SD) | 87.6 (17.3) | 93.1 (16.5) | 82.3 (21.4) | 86.7 (17.2) | 92.0 (17.8) | 82.6 (21.5) |
| p | <0.0001 | <0.0001 | ||||
a
p-values test the hypothesis that the trend within each treatment group is the same versus a single treatment group having a different trend.
UAE, uterine artery embolization.